Shahmiri M, Enciso M, Adda CG, Smith BJ, Perugini MA, Mechler A
Mounjaro and Zepbound (tirzepatide) target two: GLP-1 and GIP
The few approved oral peptides require special administration conditions and often show variable absorption between patients
During the first week, some people may notice changes in appetite, mild digestive discomfort, or a feeling of fullness as the body adapts
Instead, continue using gentle, nourishing products that support healing
Quick Links Medical Images It is important for the PCDS to build its own image bank, as such we welcome original images from our readers, especially in skin of colour: For health professionals: please download and email the declaration of consent form and images to [email protected] Medical Dictionary Please start typing below the word of any medical term that you do not understand.